| Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and morphological … N Kumar, N Sharma, R Khera, R Gupta, S Mehan Metabolic brain disease 36, 911-925, 2021 | 40 | 2021 |
| Neuroprotection by solanesol against ethidium bromide-induced multiple sclerosis-like neurobehavioral, molecular, and neurochemical alterations in experimental rats N Sharma, S Upadhayay, A Shandilya, R Sahu, A Singh, B Rajkhowa, ... Phytomedicine plus 1 (4), 100051, 2021 | 30 | 2021 |
| Dysregulation of SIRT-1 signaling in multiple sclerosis and neuroimmune disorders: a systematic review of sirtuin activators as potential immunomodulators and their influences … N Sharma, A Shandilya, N Kumar, S Mehan Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2021 | 19 | 2021 |
| Connection between JAK/STAT and PPARγ signaling during the progression of multiple sclerosis: Insights into the modulation of T-cells and immune responses in the brain N Kumar, N Sharma, S Mehan Current molecular pharmacology 14 (5), 823-837, 2021 | 19 | 2021 |
| Potential roles of glucagon-like peptide-1 and its analogues in dementia targeting impaired insulin secretion and neurodegeneration S Mehan, S Bhalla, EM Siddiqui, N Sharma, A Shandilya, A Khan Degenerative neurological and neuromuscular disease, 31-59, 2022 | 17 | 2022 |
| Forskolin, an adenylcyclase/cAMP/CREB signaling activator restoring myelin-associated oligodendrocyte destruction in experimental ethidium bromide model of multiple sclerosis T Kapoor, S Mehan, M Suri, N Sharma, N Kumar, AS Narula, ... Cells 11 (18), 2771, 2022 | 7 | 2022 |
